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AbstrAct
ObjeCtive
To review the evidence for the short term association 
between air pollution and stroke.
Design
Systematic review and meta-analysis of observational 
studies
Data sOurCes
Medline, Embase, Global Health, Cumulative Index to 
Nursing and Allied Health Literature (CINAHL), and Web 
of Science searched to January 2014 with no language 
restrictions.
eligibility Criteria
Studies investigating the short term associations (up 
to lag of seven days) between daily increases in 
gaseous pollutants (carbon monoxide, sulphur 
dioxide, nitrogen dioxide, ozone) and particulate 
matter (<2.5 µm or <10 µm diameter (PM2.5 and PM10)), 
and admission to hospital for stroke or mortality.
Main OutCOMe Measures
Admission to hospital and mortality from stroke.
results
From 2748 articles, 238 were reviewed in depth with 
103 satisfying our inclusion criteria and 94 
contributing to our meta-estimates. This provided a 
total of 6.2 million events across 28 countries. 
Admission to hospital for stroke or mortality from 
stroke was associated with an increase in 
concentrations of carbon monoxide (relative risk 1.015 
per 1 ppm, 95% confidence interval 1.004 to 1.026), 
sulphur dioxide (1.019 per 10 ppb, 1.011 to 1.027), and 
nitrogen dioxide (1.014 per 10 ppb, 1.009 to 1.019). 
Increases in PM2.5 and PM10 concentration were also 
associated with admission and mortality (1.011 per 10 
Î¼g/m3 (1.011 to 1.012) and 1.003 per 10 µg/m3 (1.002 
to 1.004), respectively). The weakest association was 
seen with ozone (1.001 per 10 ppb, 1.000 to 1.002). 
Strongest associations were observed on the day 
of exposure with more persistent effects observed 
for PM2–5.
COnClusiOn
Gaseous and particulate air pollutants have a marked 
and close temporal association with admissions to 
hospital for stroke or mortality from stroke. Public and 
environmental health policies to reduce air pollution 
could reduce the burden of stroke.
systeMatiC review registratiOn
PROSPERO-CRD42014009225.
Introduction
Outdoor air pollution is an important risk factor for car-
diovascular disease throughout the world, with partic-
ulate air pollution alone responsible for over three 
million deaths each year.1 2 Increases in concentrations 
of daily air pollution are associated with acute myocar-
dial infarction3 and admission to hospital or death from 
heart failure.4 These associations could be mediated 
through direct and indirect effects of exposure to air 
pollutants on vascular tone, endothelial function, 
thrombosis, and myocardial ischaemia.5–8
Stroke accounts for five million deaths each year and 
is a major cause of disability.9 The incidence of stroke is 
increasing, particularly in low and middle income 
countries, where two thirds of all strokes occur.10 The 
global burden of stroke related disability is therefore 
high and continues to rise. This has been primarily 
attributed to an ageing population in high income 
countries and the accumulation of risk factors for 
stroke, such as smoking, hypertension, and obesity, in 
low and middle income countries.11 12 The impact of 
environmental factors on morbidity and mortality from 
stroke, however, might be important and is less cer-
tain.13–15 Given similarities in the pathophysiology of 
acute coronary syndrome and ischaemic stroke, it is 
plausible that air pollution is also an important and 
modifiable risk factor.3 4
To provide global policy makers with the best esti-
mates of the effect of short term exposure to air pollu-
tion on risk of stroke, we systematically reviewed 
studies examining the association between air pollu-
tion and admission to hospital for stroke or mortality 
from stroke.
Methods
Databases, sources, and searches
We searched Medline and Embase (from 1948 to 21 January 
2014), Global Health, Cumulative Index to Nursing and 
Allied Health Literature (CINAHL), and Web of Science 
with detailed search terms for: “stroke”, “cerebrovascular 
WhAt Is AlreAdy knoWn on thIs topIc
Stroke is a major cause of disability worldwide with an increasing incidence, 
particularly in low and middle income countries
While exposure to outdoor air pollution is strongly associated with acute cardiac 
events, the relation between air pollution and stroke is less clear
WhAt thIs study Adds
Our findings suggest a strong association between short term exposure to both 
gaseous (except ozone) and particulate air pollution, and admission to hospital for 
stroke and mortality from stroke
These associations were strongest in low and middle income countries, suggesting 
the need for policy changes to reduce personal exposure to air pollutants especially 
in highly polluted regions
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disease”, “air pollution”, “carbon monoxide”, “sulphur 
dioxide”, “nitrogen dioxide”, “ozone”, and “particulate 
matter” (see appendix 1 for detailed search strategy). We 
also hand searched the bibliographies of all the included 
studies and relevant review articles to identify any remain-
ing studies.
selection of articles and extraction of data
Original studies were included if they evaluated short 
term associations (up to a lag of seven days) between 
carbon monoxide, sulphur dioxide, nitrogen dioxide, 
ozone, and particulate matter PM2.5 (fine particles 
<2.5 µm in size) or PM10 (coarse particles <10 µm in size) 
and admission to hospital for stroke or mortality from 
stroke (appendix 2). Admission or mortality had to be 
recorded as an end point. Our search criteria imposed 
no language restrictions. We did not include studies 
that evaluated association of long term exposure to air 
pollution and stroke (appendix 2) or abstracts, but we 
did include short reports.
One investigator (ASVS) performed the initial screen-
ing of titles and abstracts. A second investigator (KKL) 
assessed a random sample of 200 initial titles and 
abstracts during the initial screening process, and no 
cases of disagreement were found. Two investigators 
(ASVS and KKL) were involved in the examination of the 
full text reports for eligibility of studies according to our 
prespecified review protocol (PROSPERO registration 
CRD42014009225). The inter-rater agreement for eligi-
bility of studies was 0.95 (95% confidence interval 0.91 
to 0.99). ASVS and KKL independently extracted the 
required parameters of each study, and conflicts were 
adjudicated by a third author (AH). We contacted 
authors for additional data or clarification for our 
meta-analysis where these were not presented.
study design
We included both case crossover and time series studies 
(appendix 3). The case crossover design uses condi-
tional logistic regression to compare exposure in a case 
period when the event occurred with exposure in spec-
ified control periods, with adjustment for individual 
characteristics such as age, sex, and comorbidity as 
well as secular trends and seasonal patterns with a time 
stratified approach. It assumes that short term time 
varying risk factors (such as smoking) are constant 
within reference periods4 16 17 and therefore do not con-
found rapidly fluctuating parameters such as concen-
trations of air pollution and other meteorological 
parameters.
Time series studies measure the association between 
exposure and outcome with regression analysis to 
adjust for confounding factors, such as meteorological 
variables, but are less effective at controlling for secular 
trends such as seasonality.18
Data synthesis
We pooled relative risks for a standardised increment 
in pollutant concentration as follows: 10 Î¼g/m3 for 
PM2.5 and PM10, 10 ppb (parts per billion) for nitrogen 
dioxide (NO2), sulphur dioxide (SO2), and ozone (O3), 
and 1 ppm (parts per million) for carbon monoxide 
(CO). These increments were used in most studies and 
in previous meta-analysis.3 4 We calculated stan-
dardised risk estimates for each study using the follow-
ing formula:
Five studies reported natural log of relative risk and 
the corresponding t statistic value or standard error of 
mean.19–23 Studies that expressed substratified risk 
estimates by age, location, season, sex, and type of 
stroke rather than an overall risk estimate were pooled 
separately.
additional analysis
We used the shortest lag presented to derive the overall 
estimates consistent with previous studies.3 4 The tem-
poral association between air pollution and admission 
to hospital for stroke or mortality from stroke were fur-
ther stratified according to time lags. Summary esti-
mates for lag 0 (days) refer to the risk of an event per 
increment in air pollution on the day of the event. Lag 1 
refers to risk estimates per increment in air pollution 
concentrations one day before the event. Most studies 
presented single lag analysis but only a few studies 
explicitly reported use of distributed lag models 
(appendix 4). We were therefore unable to further strat-
ify studies reporting single lag analysis using distrib-
uted lag models. Several studies reported data based on 
pollutant concentrations over cumulative lags (for 
example lag 0–1 or lag 0–2) and were not suitable for 
pooling in single lag analysis.
We performed additional prespecified analysis strat-
ified by study design, age, sex, outcome, and type of 
stroke. For nitrogen dioxide and PM10 we further pro-
vided pooled estimates stratified by the nation’s income 
status as defined by the World Bank using the gross 
national income per capita.24 We provided pooled esti-
mates for stratified variables where at least three or 
more estimates were available.
risk of bias
We assessed each individual study for risk of bias across 
three parameters: selection bias, assessment of expo-
sure, and adjustment for confounders. We then carried 
out sensitivity analysis eliminating those studies with 
high risk of bias.
Selection bias
We did not have access to primary data and therefore 
were reliant on the case definitions used by the 
authors of the individual studies. Most studies (83%, 
86/103 studies), however, used ICD-9 (international 
classification of diseases, ninth revision) codes 430–
438 and ICD-10 (international classification of dis-
eases, 10th revision) codes I60-I69 (appendix 4). 
Studies that used all clinical information, including 
brain imaging, to define stroke or those that used an 
inclusive definition of stroke (ICD-9 codes 430–437 
and ICD-10 codes I60-I68) were considered to be at low 
risk of selection bias. Studies that used a less inclusive 
definition were considered to be at increased risk of 
selection bias.
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Exposure assessment
Accuracy of the measurement of exposure was difficult 
to assess because of variable reporting in the primary 
studies. The frequency of measurement (daily or inter-
mittent monitoring), however, was reported to a high 
standard, and we considered studies that used daily 
measurement to be at low risk of bias.
Adjustment of confounders
Adjustment for meteorological parameters, time trends, 
seasonality, and influenza outbreaks are summarised in 
the data supplement (appendix 4). Studies that 
adjusted for at least three confounders were considered 
to be at low risk of bias.
statistical analysis
Based on our previous analysis,4 we anticipated a larger 
degree of variation and heterogeneity in the overall 
effect estimates between studies because of different 
study designs, methods of analysis, different exposure 
lags, and geographical and population differences. As 
we did not assume that the “true effect” estimate would 
be the same across all studies, we used a prespecified 
random effects model (maximum likelihood approach) 
for our analysis to account for heterogeneity both 
within and between studies.25 We conducted prespeci-
fied subgroup analysis by study design, age, sex, out-
come, and type of stroke to explore any underlying 
source for heterogeneity.
We constructed funnel plots to examine publication 
bias (appendix 5) and assessed them for asymmetry 
using Egger’s regression test.26 We then corrected for 
asymmetry using the trim and fill method, with 
adjusted relative risks and the number of studies 
adjusted presented for each pollutant.27
Summary statistics are presented as relative risk per 
given increment in pollutant concentration. The analy-
sis was performed with comprehensive meta-analysis 
(Biostat, Englewood, NJ) and RStudio (RStudio 2013, 
version 0.98.501). Significance for pooled estimates was 
taken as a two sided P<0.05.
results
We assessed the abstracts of 2748 articles and reviewed 
238 relevant studies in depth. Of these, we identified 
103  that fulfilled the inclusion criteria (appendix 2 
and  3).13 14 20–23 28–35 61–149 Sixty nine studies used a time 
series design, 33 used a case crossover design, and one 
used both study designs incorporating over 6.2 million 
events across 28 countries (appendix 3). Twenty five (24%) 
studies presented analyses stratified by type of stroke 
(haemorrhagic and ischaemic), though only a minority of 
studies reported on haemorrhagic strokes (15 studies, 
15%). Most studies presented risk estimates for stroke 
defined from administrative databases using the ICD-9 
and ICD-10 codes (appendix 4). Most studies adjusted for 
other meteorological parameters including time trends, 
seasonality, and temperature (appendix 4). Not all studies 
provided risk estimates across all pollutants (appendix 3).
Of the 103 studies that met the inclusion criteria, we 
excluded nine studies from meta-analysis. Of these nine 
studies, five presented estimates as a subset of the par-
ent study and therefore only estimates from the parent 
study were included.28–32 Four studies were excluded as 
risks were presented per category of pollutant concen-
tration rather than per unit increment, the increment 
was not defined, or the effect estimates were not pre-
sented as either relative risks or odds ratios.21 33–35
There was a positive association between all gaseous 
and particulate air pollutants and admission to hospital 
for stroke or mortality from stroke, with the weakest 
association seen for ozone (fig 1). Individual forest plots 
for each of the pollutants are presented in appendix 6.
Particulate pollutants
Both PM2.5 and PM10 were positively associated with 
admission to hospital for stroke or mortality from 
stroke, with a stronger association for PM2.5. The 
increase in relative risk was 1.011 (95% confidence inter-
val 1.011 to 1.012) per 10 µg/m3 increase in PM2.5 concen-
tration (fig 1). The association between PM2.5 and stroke 
was evident on the day of the event (lag 0) and was 
present for up to two days (lag 2) before the event.
These associations persisted when we stratified by out-
come (admission or death), sex, age (>65), or study design 
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Fig 1 | association between gaseous and particulate air pollutants and admission for 
stroke or mortality from stroke stratified by time lag (days)
RESEARCH
4 doi: 10.1136/bmj.h1295 | BMJ 2015;350:h1295 | the bmj
(fig 2 and appendix 7) for either PM2.5 or PM10. Few studies 
reported summary estimates by type of stroke, but when 
they were reported, the association for PM2.5 was 1.010 
(95% confidence interval 1.008 to 1.011; I2=69%) for isch-
aemic stroke and 1.004 (0.978 to 1.029; I2=14%) for haem-
orrhagic stroke (appendix 7). Risks for ischaemic stroke 
and haemorrhagic stroke associated with PM10 exposure 
were comparable (1.002 (0.999 to 1.004; I2=23%) and 1.002 
(0.997 to 1.006; I2=0%), respectively).
gaseous pollutants
Nitrogen dioxide was the most commonly measured 
gaseous pollutant, with a 1.014 (95% confidence inter-
val 1.009 to 1.019) relative increase in risk of admission 
to hospital for stroke or mortality from stroke per 10 ppb 
increment across two million events (fig 1). Both sul-
phur dioxide (1.019 (1.011 to 1.027) per 10 ppb) and car-
bon monoxide (1.015 (1.004 to 1.026) per 1 ppm) were 
also positively associated with admission and mortality. 
Ozone however, showed only a weak association (1.001 
(1.000 to 1.002) per 10 ppb; fig 1).
These associations persisted when we stratified by 
outcome, age, and study design. All gaseous pollutants 
except ozone showed a positive and consistent relation 
with ischaemic stroke (appendix 7). Nitrogen dioxide 
exposure showed a consistent association with both 
ischaemic and haemorrhagic stroke (1.024 (95% confi-
dence interval 1.010 to 1.038, I2=56%) and 1.024 (1.003 to 
1.045; I2=42%), respectively; see appendix 7).
The association between gaseous pollutants and 
stroke was related to lag in exposure (days), with the 
strongest associations evident for pollutant concentra-
tions on the day of the event (lag 0) and diminishing 
with longer lag periods (fig 1).
stratification by category of national income
Most studies (80%) originated from high income coun-
tries, with only 21 (20%) originating from low or middle 
income countries. Both nitrogen dioxide and particu-
late matter (PM10) were commonly measured across 
high and low to middle income countries. Studies for 
these pollutants originated from Latin America (includ-
ing Brazil, Chile, and Mexico), South Africa, China, 
Thailand, Iran, and South Africa (fig 3). Most studies 
from low and middle income countries originated from 
mainland China (14 studies).
Pooled estimates from studies originating in low and 
middle income countries showed a stronger association 
than high income countries for nitrogen dioxide (1.019 
(95% confidence interval 1.011 to 1.027) v 1.012 (1.006 to 
1.017)) and PM10 (1.004 (1.002 to 1.006) v 1.002 (1.001 to 
1.003)) (fig 3). The median pollutant concentrations for 
nitrogen dioxide and PM10 were higher in low and mid-
dle income countries (median pollutant concentration 
27.6 ppb (interquartile range 23.8–29.6 ppb) for nitrogen 
dioxide and 50.2 µg/m3 (32.6–65.7 µg/m3) for PM10) than 
in high income countries (median pollutant concentra-
tion 22.6 ppb (19.4–28.3 ppb) for nitrogen dioxide and 
25.3µg/m3 (23.8–29.6 µg/m3) for PM10).
bias and heterogeneity
There was no difference in our overall effect estimates 
when we removed studies at increased risk of bias 
(appendix 8). Publication bias (Egger’s test for asymme-
try P<0.05) was observed for all pollutants except sul-
phur dioxide and PM2.5 (table; appendix 4). Adjustment 
for asymmetry with the trim and fill method did not 
alter the effect direction but, as expected, did attenuate 
the effect size. We observed heterogeneity across all pol-
lutants, and this was most evident with PM2.5 (I2=86%) 
and least evident with PM10 (I2=24%).
discussion
In this systematic review and meta-analysis, we evalu-
ated the effects of short term exposure to gaseous and 
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Fig 2 | associations across all gaseous and particulate air pollutants stratified by outcome, 
age, and study design
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particulate air pollution on admission to hospital for 
stroke or mortality from stroke. We made several 
important observations. Firstly, in over 6.2 million 
events across 28 countries throughout the world, our 
pooled analysis showed robust and clear associations 
between both gaseous and particulate air pollution 
and stroke admission or mortality. Secondly, the stron-
gest associations between air pollution and admission 
or mortality were observed from studies originating in 
low to middle income countries. Thirdly, these associ-
ations persisted when we stratified our pooled analy-
ses by study design, age, or outcome. Thus, we have 
shown that gaseous and particulate air pollutants 
have a robust and close temporal association with 
admission to hospital for stroke or stroke death. We 
suggest that improvements in air quality could reduce 
the burden of stroke.
evidence of short term exposure to air pollution and 
stroke
Over the past three decades, epidemiological studies 
including pooled analyses have shown that cardiac, 
rather than pulmonary, disease is the primary cause of 
morbidity and mortality associated with exposure to air 
pollution.36 Long term exposure studies have already 
shown strong associations between air pollution and 
stroke.37–39 While the short term effects of air pollution 
on cardiac disease, including heart failure and myocar-
dial infarction, have received much attention, it is less 
certain whether acute exposure to air pollution is a trig-
ger for cerebrovascular disease, especially stroke.3 4 11 
This is partly because the results of many short term 
exposure studies evaluating the effect of air pollution 
on stroke have been inconclusive, reflecting both the 
nature of the condition and the size of individual stud-
ies.36 Recently meta-analyses, including 12 and 45 stud-
ies, reported an association between particulate air 
pollution and stroke.40–43 To our knowledge, our study 
is the first comprehensive prespecified pooled analysis 
to examine the short term effects after exposure to gas-
eous or particulate air pollution and admission to hos-
pital for stroke or mortality from stroke across both time 
series and case crossover study designs.
Particulate matter and gaseous pollutants both 
showed a strong temporal relation with mortality 
from stroke and admission to hospital for stroke. The 
lag effects of exposure and stroke have to be inter-
preted with caution. Unlike other cardiac conditions 
such as acute myocardial infarction, decompensated 
heart failure, and sudden cardiac death, the timing of 
onset of stroke symptoms and subsequent admission 
to hospital or mortality might differ substantially.44 
Lokken and colleagues showed that in cases of acute 
ischaemic stroke, onset of symptoms occurred at a 
median of one calendar day before admission, and 
this delay in presentation is likely to underestimate 
the overall association between exposure to pollutant 
and stroke.44
aetiology of stroke and exposure to air pollution
While our analysis showed consistent associations for 
ischaemic stroke and air pollution, the association for 
haemorrhagic stroke was more variable with larger 
imprecision. Our results were similar to those from a 
smaller meta-analysis that showed identical patterns 
with type of stroke and exposure to PM2.5 and PM10.41 
While haemorrhagic and ischaemic stroke share similar 
risk factors and have a similar clinical presentation, 
they are different clinical entities.45 Heterogeneity in the 
association between air pollution and stroke subtype 
might be caused by many factors. Firstly, the mecha-
nisms linking exposure to air pollution and haemor-
rhagic stroke might differ for ischaemic stroke. 
Secondly, there were fewer estimates for haemorrhagic 
stroke, reflecting the lower incidence of this subtype, 
and therefore wider confidence intervals for these 
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(PM10) and admission to hospital for stroke or mortality from stroke in countries stratified 
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 estimates. Finally, misclassification of stroke subtype in 
those studies from countries with limited availability of 
medical imaging might have contributed to some of the 
observed heterogeneity.42 46
Particulate pollution and stroke
Exposure to PM10 showed weaker associations with 
admission to hospital for stroke or mortality from 
stroke than PM2.5, consistent with observations from 
other meta-analyses for stroke42 and acute myocardial 
infarction.3 This could reflect differences in particle 
size, with larger particles more likely to exert local pul-
monary effects whereas fine or ultrafine particles 
(PM2.5) or gaseous pollutants could cause additional 
systemic cardiovascular effects.36 In contrast, the 
adverse effect of larger particles in patients with heart 
failure was more striking, possibly reflecting indirect 
biological pathways such as the adverse effect of sym-
pathetic nervous activation on the failing heart.4 36 We 
noticed greater heterogeneity for PM2.5 than for PM10. 
These differences in heterogeneity persisted after sub-
group analysis and could reflect variation in study 
design. We were able to meta-analyse twice as many 
estimates for PM10 than for PM2.5, with an overall less 
marked but more consistent effect of exposure on 
stroke with PM10. There are several biologically plausi-
ble reasons for this. While there is a close correlation 
between PM2.5 and PM10 concentrations, epidemiologi-
cal studies have shown that the association between 
PM10 and acute cardiovascular events is primarily 
driven by the PM2.5 fraction.47 This fraction is enriched 
with ultrafine particles derived from the combustion of 
fossil fuels, which toxicology studies have suggested 
are the most potent component of particulate matter.48 
These particles are potentially small enough to translo-
cate from the lungs into the circulation and are there-
fore perhaps more likely to trigger acute cardiovascular 
episodes.49 Interestingly, all three gaseous pollutants 
derived from combustion (nitrogen dioxide, sulphur 
dioxide, and carbon monoxide) were associated with 
stroke, and this was consistent with reported associa-
tions with admission for heart failure and acute myo-
cardial infarction.3 4 36
Possible mechanisms explaining relation between 
stroke and air pollution
 Several large cohort studies have shown a positive 
association between long term exposure to ambient air 
pollution and coronary and cerebrovascular events.50–52 
Staffogia and colleagues showed that even in high 
income countries, where annual mean air pollution 
concentrations meet current international standards, 
small increases in PM2.5 were associated with a 19% 
increase in the risk of cerebrovascular disease, includ-
ing both ischaemic and haemorrhagic events.51 Long 
term exposures to PM2.5 accelerate carotid atherosclero-
sis.53 The underlying pathophysiological mechanisms 
after acute exposure to air pollutants in triggering 
stroke, however, remain unclear and might differ for 
haemorrhagic and ischaemic stroke.12 Previous con-
trolled exposure studies have shown that air pollution 
can adversely affect the vascular endothelium and 
increase activity of the sympathetic nervous system, 
resulting in vasoconstriction, increases in blood pres-
sure, ischaemia, and risk of thrombosis.5 8 54 Indeed, 
even minor increases in PM2.5 concentrations are asso-
ciated with changes in cerebrovascular haemodynam-
ics, including increased cerebrovascular resistance and 
reduced cerebral blood flow.55 Another potentially 
important effect of air pollution that is pertinent to 
stroke is the risk of atrial arrhythmias, which could pre-
dispose to thromboembolic events. It is plausible that 
the association between short term exposure to air pol-
lution and cerebrovascular events are a result of these 
important mechanistic pathways.
air pollution and stroke by income of nation
Most of the studies used to derive our pooled estimates 
originated from high income countries. The smaller 
number of studies from low and middle income coun-
tries is probably a result of less cohesive policies on air 
quality, inadequate environmental monitoring, and 
less robust disease surveillance.56 This is particularly 
concerning as it is these countries that bear a dispropor-
tionate burden of the global morbidity and mortality 
from stroke.12 More concerning are the trends for cere-
brovascular disease, where the incidence is falling by 
Pollutant concentrations and assessment for publication bias stratified by gaseous and particulate air pollutants
gaseous pollutants Particulate matter
Carbon monoxide 
(ppm)
nitrogen dioxide 
(ppb)
sulphur dioxide 
(ppb) Ozone (ppb) 2.5 (µg/m3) PM10 (µg/m3)
Increment 1 10 10 10 10 10
No of estimates 37 70 52 53 41 78
Pollutant concentration:
 Median (IQR) 0.8 (0.7–1.3) 24.4 (17.0–30.1) 6.2 (2.6–10.1) 24.2 (18.9–31.7) 15.7 (8.7–23.6) 35.3 (25.6–51.6)
 Range (min-max) 0.3–5.5 8.1–44.0 1.1–30.2 12.3–53.9 5.8–34.3 13–187.1
Publication bias:
 Egger regression test P value 0.070 0.036 0.098 0.014 0.670 <0.001
 RR (95% CI)* 1.015 (1.004 to 1.026) 1.014 (1.009 to 1.019) 1.019 (1.011 to 1.027) 1.001 (1.000 to 1.002) 1.011 (1.011 to 1.012) 1.003 (1.002 to 1.004)
 Adjusted RR (95% CI)† 1.015 (1.004 to 1.027) 1.014 (1.009 to 1.020) 1.017 (1.009 to 1.024) 1.001 (1.000 to 1.002) 1.011 (1.011 to 1.012) 1.001 (1.001 to 1.002)
 No of studies adjusted 8 6 8 7 3 24
*Relative risk derived from pooled analysis of studies.
†Relative risk adjusted for publication bias with trim and fill method.
ppm=parts per million; ppb=parts per billion.
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12% in high income countries and increasing by 12% in 
low and middle income countries.10 Urban cities in low 
and middle income countries not only experience high 
levels of ambient air pollution but also have larger daily 
fluctuations in levels.57 58 Our pooled estimates strati-
fied by region showed larger associations in low and 
middle income countries than in high income coun-
tries. Our estimates from low and middle income coun-
tries, however, predominantly come from East Asia, 
mainly mainland China followed by Latin America, 
South East Asia, and South Africa. There still remains a 
paucity of data from other highly populated regions 
including the Indian subcontinent and north and cen-
tral Africa.
limitations
Several limitations of our study should be considered. 
Firstly, unlike other cardiac conditions such as myocar-
dial infarction, case definition for stroke, especially 
when administrative data are used, might be less reli-
able.59 60 Secondly, many studies measured concentra-
tions of air pollution at remote monitoring sites, and it is 
therefore likely there will be some degree of misclassifi-
cation of exposure. While there might be good correla-
tions in measurements between pollutant 
concentrations at patient specific locations compared 
with those measured at remote stations, it is likely that 
highly urbanised city centres will not only experience 
higher concentrations but also greater fluctuations in 
concentrations. Therefore such ecological studies might 
underestimate the overall associations reported for 
stroke and air pollution. Thirdly, we did not have access 
to primary data and were not able to determine whether 
patients were included across multiple studies if there 
was partial temporal overlap between studies from the 
same geographical location. We did, however, exclude 
studies with complete geographical and temporal over-
lap during meta-analysis. Finally, we noticed significant 
heterogeneity (except for PM10) across all pollutants. 
This could be because of systemic differences in the 
baseline characteristics of the underlying population in 
addition to misclassification of both the measurement of 
pollutant and outcome. Our sensitivity analysis after 
exclusion of studies with a high risk of bias, however, 
showed similar results to the overall effect estimates.
Conclusion
Stroke remains the second most common cause of death 
and third most important cause of disability worldwide. 
Over the past 20 years many environmental studies 
have evaluated the association between outdoor air pol-
lution and stroke, with varying conclusions. Our pooled 
estimates now show a marked and close association 
between exposure to pollutants and adverse stroke out-
comes. Only a few studies originated from low or mid-
dle income countries and yet these countries experience 
the highest levels of air pollution and bear a dispropor-
tionate burden of global stroke mortality and morbidity. 
Public and environmental health policies that aim to 
reduce air pollution levels might reduce the burden of 
stroke.
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